13F HOLDINGS REPORT
Madison Avenue Partners, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001801265-25-000005
Total Value
$1.50B
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GRAHAM HLDGS CO | GHM | 245,271 | $232.1M | 15.49% |
| 2 | SOLVENTUM CORP | SOLV | 2,244,344 | $170.2M | 11.36% |
| 3 | MARKEL GROUP INC | MKL | 84,310 | $168.4M | 11.24% |
| 4 | SANDISK CORP | SNDK | 3,571,109 | $161.9M | 10.81% |
| 5 | INDIVIOR PLC | INDV | 7,922,178 | $116.8M | 7.80% |
| 6 | THERAVANCE BIOPHARMA INC | TBPH | 9,511,150 | $104.9M | 7.00% |
| 7 | GLOBUS MED INC | GMED | 1,712,148 | $101.1M | 6.75% |
| 8 | WILEY JOHN & SONS INC | 968223206 | 2,052,696 | $91.6M | 6.12% |
| 9 | SAGE THERAPEUTICS INC | 78667J108 | 6,077,065 | $55.4M | 3.70% |
| 10 | GALAPAGOS NV | GLPGF | 1,877,011 | $52.5M | 3.51% |
| 11 | MAGNERA CORP | MAGN | 3,344,005 | $40.4M | 2.70% |
| 12 | STAGWELL INC | STGW | 8,014,322 | $36.1M | 2.41% |
| 13 | KEROS THERAPEUTICS INC | KROS | 2,691,465 | $35.9M | 2.40% |
| 14 | INNOVEX INTERNATIONAL INC | INVX | 1,767,997 | $27.6M | 1.84% |
| 15 | MILLROSE PPTYS INC | 601137102 | 825,804 | $23.5M | 1.57% |
| 16 | NELNET INC | NNI | 144,214 | $17.5M | 1.17% |
| 17 | CARGO THERAPEUTICS INC | 14179K101 | 4,193,626 | $17.3M | 1.15% |
| 18 | CANNAE HLDGS INC | CNNE | 674,250 | $14.1M | 0.94% |
| 19 | APARTMENT INVT & MGMT CO | APA | 1,473,826 | $12.7M | 0.85% |
| 20 | ALUMIS INC | ALMS | 1,842,269 | $5.5M | 0.37% |
| 21 | FRANKLIN STR PPTYS CORP | 35471R106 | 2,580,357 | $4.2M | 0.28% |
| 22 | ARVINAS INC | ARVN | 500,000 | $3.7M | 0.25% |
| 23 | PLIANT THERAPEUTICS INC | PLRX | 2,230,012 | $2.6M | 0.17% |
| 24 | COLUMBUS MCKINNON CORP N Y | CMCO | 45,961 | $701,824 | 0.05% |
| 25 | SHARKNINJA INC | SN | 6,152 | $608,986 | 0.04% |
| 26 | OVID THERAPEUTICS INC | OVID | 1,311,362 | $432,618 | 0.03% |